Catalyst Wire Dossier Catalyst Wire Dossier

Ipratropium

ipratropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ipratropium, covering 2013-11-01 to 2026-08-03. Get the full timeline:

Most recent: Clinical Trial Results: Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD [Phase 4]

See pricing